4-165464443-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000402744.9(CPE):c.361C>T(p.Arg121Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000402744.9 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPE | NM_001873.4 | c.361C>T | p.Arg121Ter | stop_gained | 2/9 | ENST00000402744.9 | NP_001864.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPE | ENST00000402744.9 | c.361C>T | p.Arg121Ter | stop_gained | 2/9 | 1 | NM_001873.4 | ENSP00000386104 | P1 | |
CPE | ENST00000511992.1 | c.25C>T | p.Arg9Ter | stop_gained | 2/5 | 5 | ENSP00000423699 | |||
CPE | ENST00000431967.5 | c.25C>T | p.Arg9Ter | stop_gained | 2/4 | 4 | ENSP00000416601 | |||
CPE | ENST00000513982.5 | c.25C>T | p.Arg9Ter | stop_gained | 2/4 | 4 | ENSP00000424830 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250442Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135356
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461064Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726818
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
BDV syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2021 | - - |
Blakemore-Durmaz-Vasileiou (BDV) syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg | Jun 16, 2021 | The homozygous variant c.[361C > T]; c.[361C > T]; p.[Arg121*]; [(Arg121*)] was identified in two Syrian siblings and in one individual of Egypt origin. Parental consanguinity in both families present. All individuals show developmental delay, obesity, hyperphagia, suspected hypogonadotrophic hypogonadism and hypothyreoidism. The nonsense-variant p.(Arg121*) occurs in the catalytic domain of CPE. No homozygosity for truncating LoF variants in the general population database gnomAD (Genome Aggregation Database) has been listed to date. This variant was reported in heterozygous state one time in gnomAD. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at